Year archive

ROQUEFORT THERAPEUTICS PLC — 2024 filings

All 18 regulatory filings released by ROQUEFORT THERAPEUTICS PLC (ROQ) in 2024, sourced directly from the official regulator.

18 Filings

2024 Period

2024 filings (18)

Filing	Released	Lang
Director Share Distribution Director's Dealing	2024-12-04	English
Conversion of Convertible Loan Notes Director's Dealing	2024-11-07	English
STAT-6 siRNA Presentation Regulatory Filings	2024-11-06	English
Interim Results to 30 June 2024 Interim / Quarterly Report H1 2024	2024-09-27	English
Grant of Japan MK Cell Patent Regulatory Filings	2024-09-23	English
STAT-6 siRNA Demonstrates Efficacy in Immunology Regulatory Filings	2024-09-19	English
Grant of MK Cell Patent & Licencing Update Regulatory Filings	2024-09-02	English
Results of AGM AGM Information	2024-06-27	English
Appointment of Broker Board/Management Information	2024-06-20	English
Notice of Annual General Meeting AGM Information	2024-06-04	English
Issue of Convertible Loan Notes & Board Changes Share Issue/Capital Change	2024-05-23	English
Midkine Antibody Licencing Deal M&A Activity	2024-05-23	English
2023 ANNUAL REPORT AND FINANCIAL STATEMENTS Annual Report (ESEF) FY 2023	2024-05-01	English
Annual Report & Financial Statements - 31 Dec 2023 Report Publication Announcement FY 2023	2024-04-26	English
Annual Report & Financial Statements - 31 Dec 2023 Earnings Release FY 2023	2024-04-26	English
Response to Share Price Movement Share Issue/Capital Change	2024-04-05	English
Positive Results: Midkine mRNA and STAT-6 siRNA Earnings Release Q4 2023	2024-03-11	English
Operations Update Regulatory Filings	2024-02-06	English